|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Feb―06 |
D-Dimer as a biomarker for COVID-19 patients' illness severity and mortality: A hospital-based study from eastern Nepal |
Ankush Mittal, Mohammad Shamim Farooqui |
2 |
[GO] |
2021―Dec―31 |
Study of dynamic changes in the parameters of liver function tests in COVID-19 patients: A hospital-based study in Eastern Nepal |
Ankush Mittal, Mohammad Shamim Farooqui |
3 |
[GO] |
2021―Dec―31 |
Patient with false negative RT-PCR for COVID-19 referred to cancer hospital for lung cancer screening: A case report |
Ajay Kumar Yadav, Suman Gnawali, Sandip Mandal, Gyan Bahadur Shrestha, Gangbiao Yuan |
4 |
[GO] |
2021―Dec―31 |
mRNA COVID-19 vaccine: A future hope for cancer treatment |
Ajay Kumar Yadav, Suman Gnawali, Sandip Mandal, Gyan Bahadur Shrestha, Gangbiao Yuan |
5 |
[GO] |
2021―Dec―31 |
The Omicron variant of COVID-19: Is it the final nail in the coffin of the SARS-CoV-2 pandemic? |
Bedanta Roy, Harekrishna Roy |
6 |
[GO] |
2021―Jul―18 |
Knowledge, attitude, and practice on COVID-19 among undergraduate students of B. P. Koirala Institute of Health Sciences, Dharan, Nepal: An online cross-sectional survey |
KR Pandey, DR Panday, P Pyakurel, S Marahatta, SP Rimal, M Dali, et al. (+5) R Gyawali, Rambha Sigdel, N Bhattarai, N Limbu, GP Rauniar |
7 |
[GO] |
2021―Jul―18 |
Gastrointestinal manifestations as early symptoms to diagnose COVID-19 paediatric cases |
J Robinson, I Banerjee, A Leclézio |
8 |
[GO] |
2021―Jul―18 |
Epileptic seizures in patients with COVID-19: A systematic review of early evidences |
B Roy, I Banerjee |
9 |
[GO] |
2021―Jul―18 |
Global variants of COVID-19: Current understanding |
B Roy, JK Dhillon, N Habib, B Pugazhandhi |
10 |
[GO] |
2021―Jul―18 |
Novel drug for COVID-19: Virafin a therapeutic breakthrough |
J Robinson, I Banerjee, B Roy, A Leclézio |
11 |
[GO] |
2021―Jul―18 |
The Delta Plus variant of COVID-19: Will it be the worst nightmare in the SARS-CoV-2 pandemic? |
Bedanta Roy, Harekrishna Roy |
12 |
[GO] |
2021―Jan―02 |
Azithromycin and Hydroxychloroquine combination: The future pharmacotherapy of COVID-19 |
Ananya Shukla, Pornasha Mohabeer, Abhishek Kashyap, Jared Robinson, Indrajit Banerjee |
13 |
[GO] |
2021―Jan―02 |
COVID-19 and neurological complications: Is it alarming? |
Bedanta Roy |
14 |
[GO] |
2021―Jan―02 |
SARS-CoV-2 - an update in virology: A Narrative Review |
Poornasha Mohabeer, Indrajit Banerjee, Abishek Kashyap, Ananya Shukla, Jared Robinson, Nikhil D. Ramdhan |
15 |
[GO] |
2020―Jul―03 |
COVID-19 pandemic: How close are we for an effective therapy? |
Bedanta Roy |
16 |
[GO] |
2020―Jul―03 |
COVID-19: Recent advances in epidemiology, virology, etiopathogenesis, clinical trials and vaccine development |
Indrajit Banerjee, Poormasha Mohabeer, Ananya Shukla, Abhishek Kashyap, Jared Robinson |
17 |
[GO] |
2020―Jul―03 |
ABO blood groups as determinants to patient outcomes in SARS-CoV-2 |
Jared Robinson, Indrajit Banerjee, Brijesh Sathian, Alexandra Leclézio, Bedanta Roy |
18 |
[GO] |
2020―Jul―03 |
SARS-CoV-2: ACE inhibitors, disastrous or desirable? |
Alexandra Leclézio, Jared Robinson, Indrajit Banerjee |
19 |
[GO] |
2020―Jul―01 |
Pediatric COVID-19 Patients in Jeddah, Saudi Arabia: Clinical, Laboratory and Radiological Aspects |
Sumayyah Ahmed Nezar Kobeisy, Saleh Al Harbi, Raja Saleh Mehdawi, Dina Salem Bashammakh |